After-Hours Stock Movers 03/15: (CBIO) (IOVA) (MKFG) Higher; (SMAR) (BRDS) (S) Lower (more...)

After-Hours Stock Movers:

Catalyst Biosciences, Inc. (NASDAQ: CBIO) 18% HIGHER; announced that the company has regained full rights to CB 2782-PEG, a C3-degrader for the treatment of dry AMD (dAMD). Under the terms of the agreement, Biogen has returned the rights for further development on CB 2782-PEG and has ended the collaboration on other potential AMD treatments.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) 12.6% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug Application (IND) to proceed for its first genetically modified TIL therapy, IOV-4001, for the treatment of unresectable or metastatic melanoma and stage III or IV NSCLC.

Markforged Holding Corporation (NYSE: MKFG) 9.4% HIGHER; reported Q4 EPS of $0.02, $0.10 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $26.6 million versus the consensus estimate of $24.51 million. Markforged Holding Corporation sees FY2022 revenue of $114-123 million, versus the consensus of $120.3 million

Smartsheet (NYSE: SMAR) 8.5% LOWER; reported Q4 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $157.4 million versus the consensus estimate of $151.66 million. Smartsheet sees Q1 2023 EPS of ($0.20)-($0.18), versus the consensus of ($0.11). Smartsheet sees Q1 2023 revenue of $162-163 million, versus the consensus of $159.83 million. Smartsheet sees FY2023 EPS of ($0.70)-($0.62), versus the consensus of ($0.27). Smartsheet sees FY2023 revenue of $750-755 million, versus the consensus of $730.11 million.

Bird Global (NYSE: BRDS) 5.7% LOWER; reported Q4 revenue of $54 million versus the consensus estimate of $50.78 million. Bird Global sees Q1 2022 revenue of $34-36 million, versus the consensus of $49 million. Bird Global sees FY2022 revenue of at least $350 million, versus the consensus of $381.7 million.

SentinelOne, Inc. (NYSE: S) 5.1% LOWER; reported Q4 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $65.6 million versus the consensus estimate of $60.65 million. SentinelOne, Inc. sees Q1 2023 revenue of $74-75 million, versus the consensus of $68.2 million. SentinelOne, Inc. sees FY2023 revenue of $366-370 million, versus the consensus of $346.2 million.

Caleres (NYSE: CAL) 4.4% HIGHER; reported Q4 EPS of $0.91, $0.24 better than the analyst estimate of $0.67. Revenue for the quarter came in at $679.3 million versus the consensus estimate of $677.21 million. Caleres sees FY2022 EPS of $3.75-$4.00, versus the consensus of $4.03.

Allbirds, Inc. (NASDAQ: BIRD) 4.2% HIGHER; CFO, Michael Bufano, bought 25,000 shares on 03/14/22 at an average price of $5.1661. The value of the transaction was $129,152

Butterfly Network (NYSE: BFLY) 3.3% HIGHER; Director, Larry Robbins of Glenview Capital, bought 500,000 shares through the hedge fund.

You May Also Be Interested In

• After-hours movers: Meta, Ford, IBM, ServiceNow and more
• AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab
• After-hours movers: Alphabet, Microsoft, Snap, Intel, and more